Get the Stockscreener App
8.65
2.13%
0.18
Pre-market:
8.52
-0.13
-1.50%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Viatris Inc stock is traded at $8.65, with a volume of 11.93M.
It is up +2.13% in the last 24 hours and down -0.12% over the past month.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
See More
Previous Close:
$8.47
Open:
$8.655
24h Volume:
11.93M
Relative Volume:
0.88
Market Cap:
$9.64B
Revenue:
$15.05B
Net Income/Loss:
$-883.30M
P/E Ratio:
-11.69
EPS:
-0.74
Net Cash Flow:
$1.89B
1W Performance:
+6.40%
1M Performance:
-0.12%
6M Performance:
-25.56%
1Y Performance:
-25.43%
1-Day Range:
$8.52
$8.74
1-Week Range:
$8.12
$8.74
52-Week Range:
$6.85
$13.55
Viatris Inc Stock (VTRS) Company Profile
Name
Viatris Inc
Sector
Phone
(724) 514-1465
Address
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
8.65 | 9.64B | 15.05B | -883.30M | 1.89B | -0.74 |
|
ZTS
Zoetis Inc
|
157.44 | 68.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.32 | 47.30B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.70 | 45.89B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.19 | 17.90B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.60 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-24 | Resumed | Jefferies | Buy |
| Oct-23-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-23-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-24-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-17-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-27-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-10-22 | Upgrade | UBS | Sell → Neutral |
| Nov-08-22 | Upgrade | Piper Sandler | Underweight → Neutral |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Jun-14-22 | Initiated | UBS | Sell |
| May-10-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Mar-01-22 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-01-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-15-21 | Initiated | Citigroup | Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Mar-08-21 | Downgrade | Goldman | Buy → Neutral |
| Mar-02-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-21 | Initiated | Argus | Hold |
| Dec-14-20 | Initiated | Bernstein | Mkt Perform |
View All
Viatris Inc Stock (VTRS) Latest News
Long Term Trading Analysis for (VTRS) - news.stocktradersdaily.com
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider
SWKS DEADLINE TOMORROW: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Skyworks Solutions, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SWKS - GlobeNewswire Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before ... - Eagle-Tribune
Shareholders That Lost Money on Viatris Inc. (VTRS) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Viatris Inc [NASDAQ: VTRS] Sees Increase in Stock Value - knoxdaily.com
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
VIATRIS (VTRS) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By June 3, 2025 - TradingView
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc. ... - Bluefield Daily Telegraph
Viatris Q1 Earnings Release: What's in Store for the Stock? - TradingView
Shareholders that lost money on Viatris Inc.(VTRS) should contact Levi & Korsinsky about pending Class ActionVTRS - PR Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PR Newswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel - Bluefield Daily Telegraph
INVESTOR ALERT: Berger Montague Advises Viatris (VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 - TradingView
VTRS stock’s current quarter earnings estimates: What analysts predict? - uspostnews.com
Shareholders that lost money on Viatris Inc. (VTRS) Urged to Join Class Action – Contact The ... - Eagle-Tribune
Shareholders that lost money on Viatris Inc. (VTRS) Urged to Join Class Action – Contact The Gross Law Firm to Learn More - TradingView
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of - Bluefield Daily Telegraph
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS - GlobeNewswire
VIATRIS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc.VTRS - TradingView
Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider
Viatris Inc. (VTRS): Among the Worst Performing Stocks in S&P 500 So Far in 2025 - Insider Monkey
VIATRIS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Viatris Inc. - GlobeNewswire Inc.
NET POWER SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NET Power Inc. - GlobeNewswire Inc.
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit - PR Newswire
Viatris Inc (VTRS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Does Viatris Inc (VTRS) offer a good opportunity for investors? - Sete News
Deadline Alert: Viatris Inc. (VTRS) Investors Who Lost - GlobeNewswire
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - GlobeNewswire
Viatris Inc. (VTRS): One of the Cheap Quarterly Dividend Stocks to Buy Now - Yahoo Finance
Viatris Inc [VTRS] is -33.73% lower this YTD. Is it still time to buy? - dbtnews.com
VTRS ALERT: Viatris Inc. (NASDAQ:VTRS) Investors are - GlobeNewswire
Levi & Korsinsky Notifies Viatris Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineVTRS - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Viatris, Canopy Growth, Everus, and BigBear and Encourages Investors to Contact the Firm - GlobeNewswire
Viatris Inc. (VTRS): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential - EMEA Tribune
Viatris Inc. (VTRS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
VTRS’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming DeadlinesVTRS - PR Newswire
Viatris on track to close seventh straight session of gains - MSN
Shareholders of Viatris Inc. Should Contact The Gross Law Firm Before June 3, 2025 to Discuss - Bluefield Daily Telegraph
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein - GlobeNewswire
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Viatris Inc. - Bluefield Daily Telegraph
What To Expect From Viatris' Q1 2025 Earnings Report - Barchart.com
What to Expect From Viatris' Q1 2025 Earnings Report - Inkl
Contact The Gross Law Firm by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS) - PR Newswire
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - FinancialContent
VTRS SHAREHOLDER REVIEW: Viatris Inc. (NASDAQ:VTRS) was - GlobeNewswire
Viatris Inc Stock (VTRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):